Literature DB >> 18721275

HLA-G polymorphism and transitional cell carcinoma of the bladder in a Brazilian population.

E C Castelli1, C T Mendes-Junior, J L Viana de Camargo, E A Donadi.   

Abstract

The morphologic appearance and clinical behavior of the human urinary bladder papillary transitional cell carcinoma (TCC) probably result from a complex interaction between carcinogenic insults and host resistance during the patient's life. While the main recognized risk factors are of environmental origin (e.g. smoking), relatively little information exists about the susceptibility to TCC development. The human leukocyte antigen G (HLA-G) molecule plays an important role in immune response regulation and has been implicated in the inhibition of the cytolytic function of natural killer and cytotoxic T cells. Several lines of evidence indicate that HLA-G polymorphisms influence the expression level and production of different HLA-G isoforms. The aim of this study was to explore a possible influence of the HLA-G polymorphism on the susceptibility to urinary bladder TCC development and progression in smokers and nonsmokers Brazilian subjects. The HLA-G locus was found to be associated with susceptibility to TCC development and progression. The G*0104 allelic group (specially the G*010404 allele) and the G*0103 allele were associated with a tobacco-dependent influence on TCC development. The G*0104 group was associated with progression to high-grade tumors, irrespective of smoking habit, while the G*0103 allele was associated to high-grade tumor only in smoking patients. Our results are an evidence that the HLA-G locus itself, or as part of an extended haplotype encompassing this chromosome region (particularly the HLA-A given the high linkage disequilibrium observed between them in this data series), may be associated with TCC susceptibility and tumor progression, suggesting a tobacco-dependent influence of these polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721275     DOI: 10.1111/j.1399-0039.2008.01091.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  9 in total

1.  Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity.

Authors:  A Sabbagh; P Luisi; E C Castelli; L Gineau; D Courtin; J Milet; J D Massaro; H Laayouni; P Moreau; E A Donadi; A Garcia
Journal:  Genes Immun       Date:  2013-12-19       Impact factor: 2.676

2.  Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.

Authors:  Tao Li; Haohai Huang; Dan Liao; Huahuang Ling; Bingguang Su; Maode Cai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

Review 3.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

Review 4.  The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.

Authors:  Fabrício C Dias; Erick C Castelli; Cristhianna V A Collares; Philippe Moreau; Eduardo A Donadi
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

5.  Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity.

Authors:  Erick C Castelli; Jaqueline Ramalho; Iane O P Porto; Thálitta H A Lima; Leandro P Felício; Audrey Sabbagh; Eduardo A Donadi; Celso T Mendes-Junior
Journal:  Front Immunol       Date:  2014-10-06       Impact factor: 7.561

6.  Genetic variation in the HLA-G 3'UTR 14-bp insertion/deletion and the associated cancer risk: evidence from 25 case-control studies.

Authors:  You Jiang; Jun Lu; Yue-E Wu; Xin Zhao; Liang Li
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

Review 7.  The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors.

Authors:  Simon Jasinski-Bergner; Markus Eckstein; Helge Taubert; Sven Wach; Christian Fiebig; Reiner Strick; Arndt Hartmann; Barbara Seliger
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

8.  Human leukocyte antigen-G (HLA-G) polymorphism and expression in breast cancer patients.

Authors:  Seri Jeong; Seho Park; Byeong-Woo Park; Younhee Park; Oh-Joong Kwon; Hyon-Suk Kim
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

9.  Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.

Authors:  Amira Ben Amor; Karine Beauchemin; Marie-Claude Faucher; Agnes Hamzaoui; Kamel Hamzaoui; Michel Roger
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.